Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Partial Response to First-Line Crizotinib in an Elderly Male Patient with ROS1 Translocation-Positive Lung Cancer.

Overbeck TR, Schmitz K, Engelke C, Sahlmann CO, Hugo S, Kellner L, Trümper L, Schildhaus HU.

Case Rep Oncol. 2016 Mar 10;9(1):158-63. doi: 10.1159/000444745. eCollection 2016 Jan-Apr.

2.

See the unseen: Mesorectal lymph node metastases in prostate cancer.

Hijazi S, Meller B, Leitsmann C, Strauss A, Ritter C, Lotz J, Meller J, Trojan L, Sahlmann CO.

Prostate. 2016 Jun;76(8):776-80. doi: 10.1002/pros.23168. Epub 2016 Feb 16.

PMID:
26880517
3.

[Pathophysiology of inflammation].

Sahlmann CO, Ströbel P.

Nuklearmedizin. 2016;55(1):1-6. German.

PMID:
26875429
4.

Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy.

Meller B, Bremmer F, Sahlmann CO, Hijazi S, Bouter C, Trojan L, Meller J, Thelen P.

EJNMMI Res. 2015 Dec;5(1):66. doi: 10.1186/s13550-015-0145-8. Epub 2015 Nov 17.

5.

Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.

Sahlmann CO, Meller B, Bouter C, Ritter CO, Ströbel P, Lotz J, Trojan L, Meller J, Hijazi S.

Eur J Nucl Med Mol Imaging. 2016 May;43(5):898-905. doi: 10.1007/s00259-015-3251-y. Epub 2015 Nov 12.

PMID:
26563122
6.

Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.

Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter CO, Lotz J, Schildhaus HU, Trojan L, Sahlmann CO.

Prostate. 2015 Dec;75(16):1934-40. doi: 10.1002/pros.23091. Epub 2015 Sep 10.

PMID:
26356236
7.

Multimodal cardiac imaging of a postinfarction subvalvular left ventricular aneurysm.

Menke J, Sahlmann CO.

BMJ Case Rep. 2015 Feb 25;2015. pii: bcr2014208139. doi: 10.1136/bcr-2014-208139. No abstract available.

PMID:
25716156
8.

Erratum to: The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas.

Kretschmer L, Bertsch HP, Bardzik P, Meller J, Hellriegel S, Thoms KM, Schön MP, Sahlmann CO.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):360-1. doi: 10.1007/s00259-014-2968-3. No abstract available.

PMID:
25492805
9.

The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas.

Kretschmer L, Bertsch HP, Bardzik P, Meller J, Hellriegel S, Thoms KM, Schön MP, Sahlmann CO.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):231-40. doi: 10.1007/s00259-014-2914-4. Epub 2014 Oct 15. Erratum in: Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):360-1.

PMID:
25316295
10.

Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells.

Tsaknakis B, Schaefer IM, Schwörer H, Sahlmann CO, Thoms KM, Blaschke M, Ramadori G, Cameron S.

Med Oncol. 2014 Jan;31(1):813. doi: 10.1007/s12032-013-0813-3. Epub 2013 Dec 14.

PMID:
24338272
11.

18F-FDG PET/CT of a rectal carcinoma and a sigmoid adenoma.

Menke J, Schaefer IM, Sahlmann CO.

Postgrad Med J. 2013 Nov;89(1057):673-4. doi: 10.1136/postgradmedj-2012-131383. Epub 2013 Jul 24. No abstract available.

PMID:
23884701
12.

Alpha emitter radium-223 and survival in metastatic prostate cancer.

Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators.

N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.

13.

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival.

Homayounfar K, Bleckmann A, Conradi LC, Sprenger T, Lorf T, Niessner M, Sahlmann CO, Meller J, Liersch T, Ghadimi BM.

Int J Colorectal Dis. 2013 Jul;28(7):1009-17. doi: 10.1007/s00384-013-1648-2. Epub 2013 Feb 1.

14.

Individualized surgery: gamma-probe-guided lymphadenectomy in patients with clinically enlarged lymph node metastases from melanomas.

Kretschmer L, Sahlmann CO, Bardzik P, Mitteldorf C, Helms HJ, Meller J, Schön MP, Bertsch HP.

Ann Surg Oncol. 2013 May;20(5):1714-21. doi: 10.1245/s10434-012-2841-1. Epub 2013 Jan 12.

15.

Patients with autoimmune thyroiditis. Prevalence of benign lymphadenopathy.

Sahlmann CO, Meller J, Siggelkow H, Homayounfar K, Ozerden M, Braune I, Kluge G, Meller B.

Nuklearmedizin. 2012;51(6):223-7. doi: 10.3413/Nukmed-0484-12-03. Epub 2012 Oct 1.

PMID:
23042429
16.

Blastomatoid pulmonary carcinosarcoma: report of a case with a review of the literature.

Schaefer IM, Sahlmann CO, Overbeck T, Schweyer S, Menke J.

BMC Cancer. 2012 Sep 25;12:424. doi: 10.1186/1471-2407-12-424. Review.

17.

Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment.

Homayounfar K, Bleckmann A, Conradi LC, Sprenger T, Beissbarth T, Lorf T, Niessner M, Sahlmann CO, Meller J, Becker H, Liersch T, Ghadimi BM.

Int J Colorectal Dis. 2012 Oct;27(10):1359-67. Epub 2012 Mar 21.

18.

[(68)Ga-labeled peptides for clinical trials - production according to the German Drug Act: the Göttingen experience].

Meller B, Angerstein C, Liersch T, Ghadimi M, Sahlmann CO, Meller J.

Nuklearmedizin. 2012;51(2):55-64. doi: 10.3413/nukmed-0435-11-10. Epub 2012 Feb 17. German.

PMID:
22249368
19.

Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.

Hohloch K, Sahlmann CO, Lakhani VJ, Wulf G, Glass B, Hasenkamp J, Meller J, Riggert J, Trümper L, Griesinger F.

Ann Hematol. 2011 Nov;90(11):1307-15. doi: 10.1007/s00277-011-1199-y. Epub 2011 Mar 1.

PMID:
21360108
20.

Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs).

Meller J, Liersch T, Oezerden MM, Sahlmann CO, Meller B.

Q J Nucl Med Mol Imaging. 2010 Dec;54(6):582-98. Review.

PMID:
21221067
Items per page

Supplemental Content

Loading ...
Write to the Help Desk